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ABSTRACT 
 
Examining Variations of Patient Visit Characteristics on Lifestyle Counseling Among Diabetic 
Patients 
 
By 
 
Ashley Alesia McCook 
 
August 7th, 2018 
 
 
INTRODUCTION:  Hyperglycemia is associated with increased risk of diabetic complications; 
however, this can be reduced by the maintenance of healthy blood glucose levels. Substantial 
evidence suggests that glycemic control can improve health outcomes in diabetic patients; 
however, a lack of translation to practice of interventions' effectiveness. Several barriers to 
providing counseling may exist. The likelihood of counseling has been hypothesized to be 
associated with patient, physician and system characteristics. 
AIM: Explore variations in lifestyle counseling for US adult diabetic patients along with patient, 
physician, and system characteristics during clinical visit using the NAMCS dataset. 
METHODS: Clinical patient visit data was obtained from the National Ambulatory Medical 
Care Survey [NAMCS] 2012-2015 for analysis. Multivariate logistic regression was utilized to 
calculate estimates and adjusted odds ratios for characteristics associated with the likelihood of 
intervention for diabetic patients. 
RESULTS: Among the characteristics included in the statistical models for counseling, were 
found to be significantly associated with the likelihood of being offered diet and exercise 
counseling in the logistic model. These include HbA1c testing [OR=1.615]; Shift, hourly 
physicians [OR=5.370]; EMR meeting DHHS criteria [OR=6.529]; patient race [Hispanic 
OR=2.074, Black OR=1.337]; physician specialty [cardiology OR=1.402]; patient’s history of 
chronic conditions [obesity OR=2.524, OR=4.264]. 
DISCUSSION: More than patient level characteristics are associated with the likelihood of 
counseling. Physician and system-level characteristics are also significantly associated with the 
likelihood intervention. Identifying the sources of variations could not only better understand 
barriers to executing counseling but also effectively reducing the burden of diabetes and other 
co-morbidities. 
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CHAPTER I: INTRODUCTION 
 
Background  
 
 Diabetes mellitus, Type 2 [DM II] is a chronic metabolic disease whose prevalence has 
been rapidly increasing across the population. Due to this trend, diabetes quickly has become an 
epidemic in both developed and underdeveloped countries worldwide. The increased prevalence 
of DM II coupled with an influx of an aging population has only exacerbated the burden for 
healthcare providers to combat the negative impact on the population’s health (Alim, 2017). 
Diabetes accounts for significant part of healthcare expenditures, health related disabilities, and 
negatively impacts the workforce. According to the Center of Disease Control, medical costs and 
loss of work wages for people with a diagnosis of diabetes total to 327 billion dollars yearly in 
the United States of America (Prevention, 2017).  Currently, in the U.S. population, 30.3 million 
people have diabetes [23.1 million officially diagnosed but 7.2 million people are undiagnosed] 
however 84.1 million adults [18 years or older] are pre-diabetic (Prevention, 2017).  
People living with this disease are more susceptible to other complications that can 
hinder their quality of life and lead to premature death. Patients with hyperglycemia are 
approximately two times more likely to be diagnosed with some form of cardiovascular disease 
or suffer from a cerebrovascular event [i.e., stroke] than their counterparts without 
hyperglycemia (Prevention, 2017).  Diabetes is the leading cause of renal failure, limb 
amputations, and retinal complications [adult onset-blindness] (Prevention, 2017). Apart from 
obesity, diabetes is one of the gateways to other severe and potentially fatal chronic diseases, 
adding to the trend of patients living with comorbidities.  
For example, according to a New York Times article there is an association between 
pancreatic cancer and Type II diabetes. Although diagnosis of pancreatic cancer is rare, it’s 
predicted that pancreatic cancer will be the second most deadly form of cancer in 2030 (Brody, 
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2018). Due to delay of symptoms and early detection biomarker test, survival rates for patients 
with this diagnosis is very poor. People who are more likely to develop pancreatic cancer have 
one of the following risk factors: 
• Older age 
• African-American or Ashkenazi Jew 
• Two or more first-degree relatives who have cancer 
Tobacco smoking, originally known risk factor, accounts for 20-25% of pancreatic cancer 
despite the decline over the past few decades (Brody, 2018). However, it’s discovered that the 
main risks of pancreatic cancer and deaths are obesity, Type II diabetes, and metabolic 
syndrome. The severity of obesity and Type II diabetes is attributable to the rise of pancreatic 
cancer. When the body resists insulin, the pancreas produces excess insulin promoting cell 
growth including cancer cells. It’s stated that 50-80% of pancreatic cancer patients have diabetes 
or impaired glucose tolerance (Brody, 2018). However, research has discovered that patients 
who have better glycemic control through metformin reduce the risk of pancreatic cancer and 
better rates of survival. 
Although currently no cure for this chronic disease, there are different methods of 
hyperglycemia control such as oral hypoglycemic agents, insulin sensitizers [metformin], 
biguanide, and more innovative medications. However, there are other treatment modalities such 
as lifestyle modification that focus on nutrition and physical activity that are not cost effective 
over time but are useful in controlling blood sugar level in patients who have diabetes. 
Type II Diabetes versus Other Diabetes 
 
 Diabetes is a chronic condition that disrupts the way a person’s body metabolizes 
glucose. This dysfunction occurs in the body resisting a hormone created by the pancreas called 
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insulin to regulate blood sugar or doesn’t produce an adequate amount of insulin to control a 
consistent glucose level (Knowler, Barrett-Connor, Fowler, & Hamman, 2002). Untreated 
hyperglycemia over time can cause health complications such as failure of vital organs including 
the eyes [retinopathy], kidneys [nephropathy], heart, etc. (Ali MK, 2013). There are three types 
of diabetes: Type I, Type II, and gestational diabetes. 
 Type I diabetes, also known as juvenile diabetes, is caused by an autoimmune response 
that destroys pancreatic cells preventing the body from producing insulin. Approximately five 
percent of people diagnosed with diabetes have Type I. Although the exact cause of Type I 
diabetes is unknown, potential attributable factors causing Type I diabetes include genetics, 
exposure to viruses, and other environmental factors. 
 Gestational diabetes is an ephemeral condition of diabetes-induced during pregnancy. An 
infant that is born to a mother diagnosed with gestational diabetes has an increased risk of having 
health complications. Although gestational diabetes majority of the time is temporary, 
gestational diabetes predisposes women to an increased likelihood of being diagnosed with Type 
II diabetes. Also, the offspring born to women with gestational diabetes have increased odds to 
become obese during adolescence and developing Type II diabetes later in life.  
 Type II diabetes or adult-onset diabetes is slightly different from Type I diabetes. 
Although under the condition of DM II insulin is produced, the body is not producing an 
adequate amount of insulin or is resistant to the insulin produced. Because of this malfunction, 
the body is unable to maintain a consistent and normal glucose level [hyperglycemia]. Most 
patients diagnosed with diabetes have DM II. Unlike Type I diabetes where it is not known how 
to prevent this disease, DM II can be prevented or delayed with lifestyle changes such as 
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maintaining a healthy weight, eating a balanced, healthy diet, and getting an adequate amount of 
physical activity consistently (Balas, 1998). 
Risk Factors & Prevention 
 Although the different types of diabetes possess the same consequences when it comes to 
the longevity and complications of the patient’s health, Type II diabetes is a bit more preventable 
based on specific risk factors and method of prevention. Some of the known risk factors that 
increase the likelihood of developing diabetes are classified as clinically overweight or obese, 45 
years of age or older, having a family history of diabetes, race/ethnicity [people of African, 
Hispanic/ Latino, American Indian or Alaska Native descent have a higher incidence of diabetes] 
, diagnosis of pre-diabetes [hyperglycemia- abnormal glucose level but not high enough for 
diabetes diagnosis], physical active less than 3 days per week,  and medical history of 
hypertension; hyperlipidemia; and history of gestational diabetes during pregnancy (Kreuter, 
Scharff, Brennan, & Lukwago, 1997).  However, there are many methods of prevention to 
decrease the likelihood of developing DM II and mitigate the effects of diabetes such as 
consuming a healthy balanced diet and getting an adequate amount of physical activity to 
consistently control glycemic level in diabetic patients (Knowler, Barrett-Connor, Fowler, & 
Hamman, 2002). Even though the strong empirical evidence of lifestyle interventions are more 
effective at improving glycemic control in patients diagnosed with diabetes, other studies that 
reflect a lack of effectiveness of translation from clinical research into practice. It is estimated 
that it would take approximately take 17 years for a small percentage of research to integrate into 
medical practice (Balas, 1998). 
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Aims of the study  
 Our data analysis for this research study aims to explore the variations in counseling 
offered based on patient, provider, and system characteristics for patients diagnosed with Type II 
diabetes to discover the potential characteristics that influence the likelihood of receiving an 
intervention.  Using the National Ambulatory Medical Care Survey (NAMCS), the study’s 
analysis will address the following research questions: 
Question 1: Are patient characteristic variations associated with the likelihood of adult 
diabetic patients being offered lifestyle counseling in the US? 
Question 2: Are provider and system characteristic variations associated with the 
likelihood of adult diabetic patients being offered lifestyle counseling in the US? 
 Despite the trends of lifestyle counseling offered to diabetic patients in the ambulatory 
setting not being well known and other studies’ attempts to conduct analysis that lacked 
statistical power and quality of complete data for study analysis, our goal is to provide more 
information for community feedback to better identify and understand the barriers from these 
selected levels of characteristics when it comes to receiving lifestyle counseling.  
CHAPTER II: REVIEW OF THE LITERATURE  
 
 Statistics showed a population increase of diagnosis of diabetes from 3.5% in 1990 to 
7.9% in 2008. A study whose objective was to update the national trends of diabetes 
[undiagnosed or diagnosed] discovered the mean BMI of the adult U.S. population increased 
significantly [p<0.001] (Menke A, 2015). The prevalence of obesity changed significantly from 
21.1% in 1988-1994 to 32.4% among people diagnosed with diabetes in 2005-2010 (Menke A, 
2015). Simultaneously, the prevalence of total diabetes [diagnosis plus hemoglobin A1c ≥ 6.5] 
went from approximately 6.2% [5.6%-6.8%] in 1988-1994, 8.8% [8.1-9.6%] in 1999-2004, and 
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9.9% [9.2%-10.7%] 2005-2010 (Menke A, 2015).  A similar trend increase was observed when 
diagnosed with diabetes and fasting glucose count [≥ 126 mg/dL] (Menke A, 2015). However, 
more alarming is the prevalence of undiagnosed diabetes that reflects a similar increasing trend.  
Unfortunately, for ethnic minorities and geriatric population the prevalence of diabetes is 
substantially greater including undiagnosed diabetes, treatment type, and blood sugar control in 
comparison to their white counterparts. Non-Hispanic Black prevalence for diabetes is 15.4% 
versus their white counterparts at 8.6%. Mexican-American prevalence fair no better when it 
comes to diabetes 11.6% versus 8.6% whites (Selvin, Parrinello, Sacks, & Coresh, 2014).  When 
focusing on medication usage among diagnosed patients, prevalence still varies among different 
ethnic groups. For example, reports on diabetic patients utilizing medication-only shows that 
only 52% [46.2%- 56.7%] of Non-blacks and 43% [38.1%-49.0%] of Mexican-American had a 
HbA1c level were less than 7.0% in comparison to 57% of Non-Hispanic White (Selvin, 
Parrinello, Sacks, & Coresh, 2014). Once adjustments were made in the model to include 
demographic and adiposity factors, it strongly attenuated and explains the total diabetes 
prevalence in the U.S. Other studies have discovered an association between diabetes functional 
status, mobility, cognition, fracture risk and life expectancy which explains the high burden of 
diabetes in the older adult U.S. population. The high burden of diabetes, prediabetes, poor rates 
of glycemic control [even patients treated with medications] has only increased the burden of 
diabetic patients having a greater risk for diabetic complication and developing multiple 
comorbidities (Morrison, Shubina, & Turchin, 2012). Despite the study’s findings revealing that 
the prevalence of undiagnosed diabetes was relatively stable and increase of glycemic control 
among diabetic patients, which may be attributable to improvements in initiatives for screening 
and diagnosis the chronic illness, there is still an issue of a significant portion of the population 
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that isn’t achieving the normal hemoglobin A1c levels especially among blacks and Mexican-
Americans (Albright AL & EW, 2013). Because of these additive burdens, the health of the 
population has an increased likelihood of declining at an alarming rate. However, these trends 
influence the population health but also a significant increase in the healthcare expenditure to 
compensate for the medical crisis.   
A study conducted by the Institute for Health Metrics examined the estimates of national 
spending on personal health care and public health when stratifying by disease, age, sex, and 
type of care in the U.S. population. The study utilized government budgets, insurance claims, 
surveys from medical facilities, household surveys, and other U.S. records from 1996 to 2013 to 
estimate spending based on 155 medical conditions and 38 age and sex groups. Although the 
study found ischemic heart disease and cerebrovascular to be the most significant condition of 
spending at approximately 231.1 billion dollars in 2013, diabetes along with a few other health 
conditions trailed slightly behind as the second largest condition with spending of 224.5 billion 
dollars (Dieleman, Baral, Birger, Bui, & al., 2016). Regarding resource and retail pharmaceutical 
expenditure, total diabetes takes the lead with approximately 101.4 billion on resources, and 
57.6% accounted for pharmaceutical spending (Dieleman, Baral, Birger, Bui, & al., 2016). The 
spending on diabetes was incurred by the 45 years and older population which further aligns with 
the high burden of diabetes in the aging population from previous studies. With these current 
trends, it explains Diabetes’ significant attribution of morbidity and mortality with an estimated 
cost of 245 billion dollars in health resources and lost productivity with no slowing down if 
appropriate measures are not taken in the future (Dieleman, Baral, Birger, Bui, & al., 2016). 
Despite these alarming statistics that are affecting the U.S. population's health and economy, 
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there is extensive research conducted to discover a solution to the medical and financial crisis of 
diabetes. 
A double-blind clinical trial study examined the effectiveness of different treatment 
methods that would delay or prevent the development of diabetes. During the study, 3234 pre-
diabetic patients from 27 centers were randomly allocated to three treatment groups: placebo, 
metformin [hyperglycemic medication], and intensive lifestyle intervention [focus on weight loss 
and physical activity]. Participants were of the age of 25 years or older, BMI of 24 or higher, and 
plasma glucose concentration of 5.3 to 6.9 mmol per liter in a fasting state and 7.8 to 11.0 mmol 
per liter two hour after a 75-g oral glucose load, and that weren’t taking altering glucose 
tolerance medication or other illness that compromise the patients’ life expectancy.  
At the end of the follow-up period, the cumulative incidence of diabetes was lower in the 
lifestyle intervention group and metformin. The incidence of diabetes in the lifestyle intervention 
group was approximately 58% lower and 31% of the metformin group in comparison to the 
placebo group (Morrison, Shubina, & Turchin, 2012). These results were found to be statistically 
significant even with the adjustment of baseline characteristics. The projected incidence of 
diabetes at three-years of follow-up is estimated to be 28.9%-placebo, 21.7%-metformin, and 
14.4%-lifestyle intervention groups.  
Similar trends were seen when applied to the effectiveness of restoring normal fasting 
glucose levels among the metformin and lifestyle intervention groups (Morrison, Shubina, & 
Turchin, 2012). However, the lifestyle interventions were more effective in restoring normal 
post-load glucose levels and among older participants who is the most vulnerable to diabetes. 
Similar studies conducted by the Diabetes Prevention Program in the U.S. and Finland show 
similar cumulative incidence in both research studies. The studies showed a greater than 50% 
16 
 
reduction in diabetes incidence among study participants in the intensive lifestyle intervention 
group compared to those in the placebo group (Lindstrom, Louheranta, Mannelin, Rastas, & al., 
2003).  
There is extensive research that reveals an association between electronic health record 
adoption and maturation over time to patient health outcomes coupled with hospital 
characteristics, i.e., hospital size and teaching status (Lin, Jha, & Adler-Milstein, 2018).  There is 
a growing trend in thought that integrating patient outcomes with electronic health records 
promotes patient-centered care, research, and overall population health. A U.K. study attempted 
to quantify and stratify diabetic patients’ electronic records with the intent to create a severity 
score and ability to predict the risk of future health outcome due to diabetes. The purpose of the 
study conducted in the U.K. was to find a tool for primary care physicians to take preventive 
measures according to patients’ severity of risk for chronic conditions. High performing and 
quality electronic health records systems and configuration can be influential to the patient health 
outcomes of medical practices (Zghebi, Rutter, Ashcroft, Ashcroft, & al., 2018). Characteristics 
of the dataset that proxy EEMR capabilities of every medical practice sampled will also be 
included in the studies analysis to see if variations of EEMR capabilities are associated with the 
likelihood of diet and physical activity counseling. 
Although these studies show promise of effectiveness and applicative to different 
demographics ethnically; culturally; economically diverse population, these studies lack the 
statistical power to assess the effects for subgroup analysis to detect a difference in the effect of 
treatments. Several studies have shown a lack of translation from clinical trials to clinical 
practice. It is predicted that it would take approximately 17 years for a small percentage of 
research to be integrated into the medical field (Morrison, Shubina, & Turchin, 2012). Latent 
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barriers and variation in the patient, provider, and system characteristics could explain the lack of 
counseling offered in the ambulatory setting to improve glycemic control across the population. 
CHAPTER III: METHODS AND PROCEDURES 
 
Conceptual Framework 
 Selected predictors in our analysis were based on the common factors that attribute to the 
observed burden of Type II Diabetes and variations in counseling from previous studies 
mentioned in the literature. Studies conducted that examined the prevalence and trends of U.S. 
adults observed that race/ethnicity, age, BMI were significant factors in analysis. Unadjusted 
prevalence of total diabetes where higher in age group 65 years and older when compared to 
younger counterparts (Menke A, 2015). Similar prevalence observations were seen among men 
and women. Non-Hispanic black, non-Hispanic Asian, and Hispanics when controlling for age 
had higher prevalence diabetes in comparison to their white counterparts (Menke A, 2015). BMI 
reflected similar trends in prevalence rates in different race/ethnic groups with the exception that 
non-Hispanic Asian possessed lowest BMI. However, the diabetes trend in prevalence was 
significantly increasing over time for all age groups regardless of race/ethnicity, education level, 
and income.  
Another study observed similar trends for Type II diabetes prevalence in the population. 
Despite the prevalence of glycemic control improving and stability of undiagnosed in the study 
analysis, there was a significantly greater prevalence of diabetes, undiagnosed diabetes, glycemic 
control in different ethnic groups. A difference in diabetic treatment types among ethnic minority 
groups i.e. non-Hispanic blacks and Mexican Americans was reflected in the result of analysis 
(Selvin, Parrinello, Sacks, & Coresh, 2014). A study in Nova Scotia patient examined patient 
characteristics documented in the Primary Care Practice Survey to identify predictors of whether 
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patients are provided with diet or exercise advice. Out of the 38 % [diet] and 42% [exercise] of 
patients who received advice for diet, patient who identified as a male, older than 35 years age, 
more than one chronic condition, and good professional relationship with provider were more 
likely to receive advice on diet and exercise (Sincliar, Lawson, & Burge, 2008). In terms of the 
number of chronic illness, studies have shown that there is a positive association between the 
number of chronic conditions of the patient and the likelihood of counseling (Sincliar, Lawson, 
& Burge, 2008). This means physician are inclined to provide lifestyle counseling to patients 
already sick. There is substantial evidence that patient characteristics are associated with the 
likelihood of counseling; however, evidence supports that physician characteristic play a vital 
role as well. 
  A study evaluating cholesterol management practices of physicians in the United states. 
Like previous studies patient-level variables that were observed to be associated with the 
likelihood of counseling of previous studies; however, physician characteristics added to the 
missing explanation of variations of method of counseling offered to patients. Analysis of the 
study revealed that physician specialty [cardiologist] were significantly more likely to offer 
counseling when adjusting for other patient variables. Another study that observed at risk 
cardiovascular disease in ambulatory settings rate of receiving, observed similar trends as 
previous studies mentioned. These studies provide further evidence to support the association of 
physician-level variables and lifestyle counseling offered by physicians. Patient visits with 
physician approximately 20 minutes or longer, providers seen during the visit [physician, 
physician assistants, and nurse practitioner], internists and cardiologists, insurance status, 
geographic region, and metropolitan status area of site of care were significantly associated with 
the likelihood of counseling. 
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  We hypothesize that these characteristics examined in the literature will be significant 
predictors for the analysis of the study. Patients who are severely sick or more susceptible to 
illness due age, race/ethnicity, insurance status, total number of chronic illnesses are more likely 
to receive diet and physical activity counseling. As the prevalence of BMI over 30 increases, 
more of the population are at risk for having multiple coexisting chronic illnesses (Alim, 2017). 
The prevalence of BMI has a strong association with other chronic disease such as diabetes, 
hypertension, and hyperlipidemia. Because of this significant relationship obesity could explain 
the variations in the analysis. Insurance status/type for the patients potentially explain the 
variations in odds of counseling, patients who lack access to healthcare may be less likely to be 
offered counseling. 
Physician-level characteristics such as physician specialty, medical degree possessed 
[MD vs D.O], provider seen during visit, geographic region of physician sampled, Metropolitan 
status area, ownership status of physicians, and basic compensation will be utilized in the study. 
These variables variations can reflect a difference of medical training, comfort level, and 
strategical plan of reducing the risk of disease of their patients. The severity of patient illness 
seen may be influential to how often physician recommend counseling especially with specialties 
such cardiology. The location of the physicians selected for the data could be associated with the 
outcome of interest for the study. The physician selected could treat patients that live in 
communities that lack access to appropriate healthcare, live in food desserts, severity of diseases 
burden, and sociodemographic of communities in the regions observed. 
 Although EMR capabilities has mixed reviews on its association of patient health 
outcomes. We believe that EMR capabilities would be a great reflection of system-level 
characteristics of the data sampled for the study. We hypothesize that the efficiency of EMR 
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capabilities, for example ability to access and sharing patient health information from another 
facility’s EMR system or meeting the Department of Health and Human Services criteria, would 
be associated with the variations of lifestyle counseling for diabetic patients. Efficient EMR 
capabilities and sharing PHI could give provider thorough information about the patient’s health 
to take the appropriate measures to improve patient health. This could also be associated with the 
amount of time spent with patients as well. All the variables that will be utilized in our analysis 
will encompass more characteristics that can explain the variations in proportions of counseling 
in comparison to previous studies of this nature. 
Data Sources 
 NAMCS  
The National Ambulatory Medical Care Survey [NAMCS] is a national survey collected 
by the Center of Disease Control’s National Center for Health Statistics annually since 1973.  
NAMCS was designed with the intent to meet the need for objective, reliable information about 
the provision and use of ambulatory medical services in the U.S. Physicians who are nonfederal 
employed office-based and primarily concentrated in direct patient care [including community 
health center-CHCs] were included during data collection. Specialties including anesthesiology, 
pathology, and radiology were excluded from the survey data collection.  
Each physician that participates in the data collection is randomly assigned to a 1-week 
reporting period of patient visit information. The unit of analysis in the NAMCS survey is the 
patient visit. The data for the systematic random sample of patient visits are recorded by official 
census interviewers using patient record forms. The survey data capture patient characteristics 
such as age, sex, race/ethnicity and visit characteristics such as patient's reason for visit, official 
diagnosis, services ordered or provided after patient discharge, medical treatments.  
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Along with the patient and visit characteristics collected, data about physician and 
practice characteristics are documented during the survey induction interview. NAMCS data is 
collected from physicians instead of patients with the intent to provide an analytic base that 
expands the information on ambulatory care through other National Center for Health Statistics 
surveys.  Survey data collected from 2012 through 2015 utilized a new sampling design allowing 
national estimates for all four census regions and 34 of the United States most populous states.  
For the NAMCS survey data collection process, the physician sample is composed of 
MDs and DOs from various specialties in the medical field. Physicians based on information 
from the American Medical Association and American Osteopathic Association are randomly 
selected to provide patient clinical data of 30 patients visit during their 1-week of the reporting 
period. Due to NAMCS larger sample size; the ability of national representativeness in the data; 
and the information obtained have patient, provider, and visit characteristics, NAMCS survey 
data is the most reliable for the data analysis of our research question to attempt fill in the gap of 
knowledge from prior existing studies. 
Institutional Review Board Approval 
 For the data analysis of our thesis, secondary public use data was utilized to answer the 
research questions and didn’t require IRB approval. The NAMCS survey data is a preapproved 
data source with exempt status determined by the Georgia State University IRB based on 
Institutional Review Board Policies. 
Inclusion/Exclusion Criteria  
 For the statistical analysis of this thesis, patient visits were sampled from the merged 
survey cross-sectional dataset from 2012 through 2015 consisting of 42,215 visit observations. 
The target population for this study’s analysis is U.S. adults diagnosed with Type II Diabetes. 
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The survey question that prompted the determinant of the patient’s diabetes status is "Does the 
patient now have: Diabetes mellitus (DM), Type 2” which is categorized into responses of yes or 
no. 
The following exclusion criteria are:  
• Patients that were not 18 years of age or older at the time of visit 
• Not diagnosed with Type II diabetes before being discharged from patient visit 
[excluding patients with Type I or unspecified]. 
• Patient is pregnant during observation period. 
• Any patient with missing information of lifestyle counseling was offered [defined as 
diet/nutrition counseling and physical activity counseling]. 
These observations were excluded from analysis to produce the least biased estimates for 
appropriate inferences. Once inclusion and exclusion criteria were applied to produce the sample 
of interest [U.S. adults patients diagnosed with Type II diabetes], only 3,463 resulted in the final 
sample size for the statistical data analysis of the research study.  
Predictor Variables 
 The predictor variables used for analysis were recorded by census interviewers based on 
randomly select physicians during their 1- week reporting period for the NAMCS survey from 
2012-2015. The target population for our analysis was operationalized with the diagnosis of 
Type II diabetes during the patient visit. The patient visit variables used in our analysis consisted 
of race/ethnicity, insurance type, age, sex, geographic region, metropolitan area status, patient 
visit type, tobacco use, total number chronic disease [comorbidities], time spent with physician 
during patient visit, and other diagnosed disease during patient visit [each disease documented on 
encounter forms where determined by the International Classification of Disease, Ninth 
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Revision, Clinical Modification- ICD-9-CM code]. The NAMCS forms also report provider and 
system variables such as the type of health provider seen at the visit, physician specialty, type of 
doctor, ownership status of medical practice, type of practice, basic compensation for the 
physician, owner of the facility, and electronic medical record capabilities.  
All predictors in our analysis are categorical/dichotomous due to the distribution of the 
variables were re-coded into a categorical variable because of lack of normality to be a 
continuous variable, i.e., total number of chronic disease, time spent with the provider, and 
patient's age during the visit via statistical testing. All predictors for statistical analysis have no 
more than 10% of missing observation in the dataset to prevent any bias in the analysis.[Refer to 
Figure 3.1 for full list of variables in analysis].  
Dependent Variables 
The two dependent variables of interest are the documented provision of diet and exercise 
counseling on the NAMCS survey forms collected. The outcome variables of interest from 
previous studies are the same in this analysis which is the offering of diet or exercise counseling. 
Like the independent variables selected for analysis, the outcome variables are categorized as yes 
or no response of whether physician sampled in the survey data offered counseling. 
Statistical Data Analysis  
All statistical analyses for the research study were conducted using SAS 9.4 for Windows 
software [Statistical Analysis Software System 9.4]. Each visit to the NAMCS is assigned 
appropriate patient and physician weights for each visit data collected. The patient [PATWT] and 
physician-level [PHYSWT] weights take into account the unequal selection probabilities from 
the sample design and nonresponse. Omitting the sample weights from the survey data would 
produce biased and incorrect inference. Findings in analysis wouldn’t be generalizable to the 
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larger target population, only to the sample used for analysis. All analyses take into account 
survey weights from patient weights which were available in the NAMCS datasets selected for 
the research study from 2012-2015. The patient weights were utilized in the analysis for national 
and regional estimates to represent the physicians and patients from the US observed in all four 
regions of the United States [Northeast, South, Midwest, West] and different metropolitan 
statistical area. 
 Descriptive statistics were conducted through PROC SURVEYFREQ to illustrate the 
frequency distribution of the visit, patient, provider, and system characteristics among diabetic 
patients offered both diet and exercise counseling from 2012-2015. Rao Chi-square tests were 
used on all the categorical variables from the survey data to detect any associations between the 
different characteristics and offered counseling among diabetic patients.  
Using the PROC SURVEY LOGISTICS procedure in SAS 9.4, multivariate logistics 
regression analysis was utilized to produce two models [diet and exercise counseling offerings] 
beta estimates, standard errors, p-values, and adjusted odds ratios and respective 95% confidence 
intervals of all the patient, physician, and system level characteristics examined in the analysis. 
Both constructed models of intervention counseling included physician specialty, medical 
insurance, different chronic disease conditions [hypertension, hyperlipidemia, CKD, and etc.], 
HbA1 testing offered to patient, method of basic compensation for physicians, patient’s sex, 
metropolitan statistical area, computerized capabilities: reminders for intervention/screening; 
practice share of PHI electronically, EMR meet Department of Health and Human Service 
criteria, provider type seen during patient visit, patient race/ethnicity, regions where physicians 
were randomly sampled, obesity, total chronic disease, and substance/alcohol dependence. The 
predictor variables included in the multivariate logistic regression models for analysis were 
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selected based on the previous literature of frequent contributors (Stafford, Blumenthal, & 
Pasternak, 1997) to variations and stepwise model selection procedure with an entry probability 
of p<0.01 and removal probability of p<0.05. The models for each lifestyle counseling were 
chosen based on the conceptual framework, and the best statistical model fits according to 
Akaike Information, i.e., AIC.  
Statistical analyses were performed at an alpha level of 0.05 level and 95% confidence 
intervals to determine if univariate and logistic regression analysis were statistically significant. 
CHAPTER IV: RESULTS 
 
Non-Clinical and Clinical Characteristics 
 In the NAMCS dataset utilized in the study’s analysis, we identified 42,215 patients from 
2012-2015.  After excluding patients who were younger than 18 years of age; diagnosis of a type 
of diabetes other than type II [Diabetes Mellitus type I or unspecified], pregnant during patient 
visit recorded; and missing information of diet and exercise counseling offered during patient 
visit, the final dataset was composed of 3,463 observation that fit the criteria of the study. 
 Tables 4.1 and 4.2 display the descriptive statistics of non-clinical and clinical 
characteristics of the study population by diet/nutrition counseling and physical activity 
counseling offers by randomly selected physicians. All non-clinical variables in the univariate 
analysis considered in the study reflected the patient, physician, and some medical practice 
(system) characteristics from the dataset. When comparing the weighted percentages/proportions 
of the non-clinical characteristics, proportions of intensive lifestyle counseling seem to be similar 
among diabetic patients who were offered counseling or not offered during the visit. However, 
when the Rao-Scott Chi-Square test results are examined some characteristics have statistically 
significant association with the outcome variable of interest. Patient sex [p= 0.0212], 
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Metropolitan Statistical Area status of physician location [p=0.0147], physician specialty 
[p=0.0112], and patient’s tobacco consumption status [p=0.0005], patient’s time spent with 
provider during visit [p=0.0161] were the only non-clinical characteristics statistically associated 
with the diet/nutrition offering groups. However, Metropolitan Statistical Area status of 
physician location [p=0.0374], physician specialty [p=0.0195], health provider seen [p=0.0271], 
and basic compensation of the physician randomly selected [p=0.0461] are statistically 
associated with the physical activity offering groups. 
  Table 4.2 analyzes the association between clinical characteristics, i.e., chronic 
comorbidities other than Type II diabetes and the outcome of interest in our study. Based on the 
univariate analysis of patient chronic illness, cancer[p=0.006]; history of pulmonary embolism 
[p=<0.0001]; and hyperlipidemia [p=0.0168] are statistically associated with dietary counseling. 
However, arthritis[p=0.0386] was the only clinical characteristic statistically associated with 
physical activity counseling. Obesity [p=<0.0001] is statistically associated regarding the 
offering of diet and exercise counseling. Obesity was the only clinical characteristics statistically 
significant among both intervention groups among diabetic patients. All variables with less than 
10% missing observations are included in the analysis to reduce the likelihood of inducing bias 
in the statistical models.  
Multivariate Logistic Models 
 Multivariate logistics models were fit for diet/nutrition counseling and exercise 
counseling respectively. All characteristics in the models are based on the conceptual framework 
and univariate analysis. Tables 4.3 and 4.4 display the beta estimates, standard error, adjusted 
odds ratios and 95% confidence interval for all the non-clinical and clinical variable chosen for 
the best fitting logistics models. Although majority of the variables in the logistic model 
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exhibited differences in adjusted odds ratio, only a select group of characteristics were deemed 
statistically significant in the models. 
 In model 1, the response variable for analysis was diet and nutrition counseling offered 
by a physician and predictors were selected based on univariate analysis. For the patient level 
characteristics, patients who identify as having Non-Hispanic black or Hispanic racial-ethnic 
backgrounds, have an increased likelihood of being offered dietary counseling than their Non-
Hispanic White counterparts [Non-Hispanic black OR=1.337 (0.686, 2.606) Hispanic OR=2.074 
(1.189,3.618)]. Patients who identified as Hispanic in the survey have a statistically significant 
adjusted odds ratio of counseling than their Non-Hispanic White counterparts in the analysis 
results. However, patients who identified as Non-Hispanic other had a smaller likelihood of 
counseling relative to Non-Hispanic white participants [Non-Hispanic Other OR=0.890 (0.205, 
3.868)]. Although some of the chronic conditions reveal variance in the odds of nutrition 
counseling, obesity [OR=2.524 (1.551,4.109)] and cancer [OR=0.499(0.291,0.855)] were the 
only statistically significant adjusted odds ratio. Patients who were clinically obese were 2.524 
times the odds to be offered diet counseling in comparison to patients who are not clinically 
obese. However, the opposite occurred in patients diagnosed with cancer. Cancer patients were 
0.499 times the odds to be offered counseling than patients who were not diagnosed with any 
form of cancer.  
  For the physician characteristics, there were also variations in the likelihood of diet 
counseling. When controlling for other covariates, patients who are offered HbA1c testing is 
1.615 times the odds to be offered diet counseling than patients who are not offered to test for 
HbA1c.  Surprisingly, physician’s compensation seems to be associated with diet counseling 
when adjusted for other covariates [Shift, hourly OR=5.370 (1.788, 16.128), Mix salary and 
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share billings OR=1.519 (0.811, 2.846), and Share of practice billings OR=1.344 (0.599, 3.017) 
in comparison to Fixed salary]. Physicians compensated through an hourly rate had a statistically 
significant adjusted odds ratio. Interesting, in the analysis, it was observed that physician’s 
whose specialty is Neurology/Ophthalmology had 0.195 odds of offering nutrition counseling 
than physicians in General/Family practice specialties. Also, medical practices’ electronic 
medical records have an association on counseling outcomes. For example, patients who attend a 
visit in a medical practice whose EHR meet the Department of Health and Human Services 6.529 
times the odds to be offered nutrition counseling than those who visit medical practices with 
EHR that don't meet DHHS criteria.  
 Model 2 is in respect to the physical activity counseling among diabetic patients in the 
data analysis. Like model 1, the predictors in model 1 that were adjusted where selected for the 
statistical model also there were similar variations in the odds for receiving physical activity 
counseling. However, unlike model 1 there are other interesting variations at patient and 
physician-level that wasn't observed in model 1. Cardiologists are 1.402 times the odds to offer 
diabetic patients exercise counseling than General Practice /Family Practice physicians. 
Specialties in Internal Medicine and Neurology/Ophthalmology has a statistically significant 
decrease in the likelihood of offering physical activity counseling [OR=0.443 (0.207,0.946), 
OR=0.095(0.020, 0.442)]. All racial/ethnic groups have an increased likelihood of offered 
physical activity in comparison to their white counterparts [Non-Hispanic Black OR= 
1.248(0.650, 2.397), Hispanic OR=1.566 (0.800, 3.068), Non-Hispanic Other OR=1.506 
(0.401,5.664)] despite not being statistically significant. Physicians sampled from the southern 
region were 1.340 times the odds to offer exercise counseling than physicians sampled from the 
Northeast when adjusting for other predictor variables. Obesity, when adjusted for other 
29 
 
variables in the model, has attenuated odds ratio in comparison to model 1.  Clinically obese 
patients are 4.264 times the odds of receiving physical activity counseling than patients of a 
healthy weight. Also, patients diagnosed with COPD have a statistically significant adjusted odds 
of 2.904 odds of being offered exercise counseling than patients without COPD.   
Interestingly, some characteristics decrease the likelihood of being offered exercise 
counseling. For example,  diabetic patients that suffer from chronic kidney disease have 0.200 
odds of physical activity counseling in comparison to their counterparts without CKD. As far as 
the ownership of medical practices sampled for analysis, medical practices owned by an 
insurance company or other health corporations are 0.412 times the odds to offer diabetic 
patients physical activity counseling than physician or physician group owned medical practices. 
The type of entity that owns a medical practice was observed to be statistically significant in our 
model. 
CHAPTER V: DISCUSSION AND CONCLUSION 
 
Conclusion 
 
The main objective of this study was to examine the potential variations in the patient, 
physician, and system characteristics that are associated with the likelihood of diabetic patients 
offered diet and physical activity counseling. Due to the burden of Type II Diabetes in every 
aspect of healthcare, effective uniform counseling is critical to improve population health.  At the 
end of the analysis, we observed that there are definite factors on all three levels that influence 
the variations of this intervention being offered to diabetic patients. When controlling for other 
covariates in the model for diet counseling, we observed statistically significant odds ratio for 
testing of HbA1c for diabetic patients, methods of basic compensation, current EMR meets 
DHHS criteria, provider seen during the visit, patient race/ethnicity, status of obesity, and 
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diagnosis of cancer. For the exercise counseling model, the statistically significant odd ratios 
were physician specialty; provider seen during visit; diagnosis of CKD; status of obesity; history 
of COPD; and ownership of medical practice. These results from our logistic model suggests that 
patient characteristic aren’t the only factors that can explain for the variations of likelihood of 
counseling. Previous studies that examined the effectiveness of lifestyle counseling of diabetic 
patients only focused on the variations among patient characteristic. Our results from analysis is 
very important to address the gap of translation in practice for counseling among diabetic 
patients. Variation in these characteristics reflect barriers of improving population health among 
the diabetic population. If there is knowledge of what is contributing to these barriers for diabetic 
patients, then we can better reduce the burden of diabetic complication overtime.  
Discussion 
 
 Although patient characteristics have been the primary focus on to improve the DMII 
burden of the population health, to effectively create an intervention to significantly reduce this 
burden and improve the cost of healthcare all patient visit characteristics must thoroughly be 
examined. Previous studies have shown that lifestyle intensive intervention is effective for 
increasing the likelihood of diabetic patients consistently controlling their glycemic levels and 
decreasing the likelihood of having diabetic complications. However, the lack of translation from 
clinical trials to clinical practice may be attributable to the lack of attention to physician and 
medical practice.  
 The following characteristics were observed to be statistically significant in our model, 
including HbA1c testing [OR=1.615]; Shift, hourly physicians [OR=5.370]; EMR meeting 
DHHS criteria [OR=6.529]; patient race [Hispanic OR=2.074, Black OR=1.337]; physician 
specialty [cardiology OR=1.402]; patient’s history of chronic conditions [obesity OR=2.524, 
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OR=4.264. As stated in previous studies and reiterated in our analysis, patients who identify in 
certain racial/ethnic groups and possess BMI over 30 [obese] are more likely to be recommended 
diet or exercise counseling. For physician-level characteristics, physicians who work hourly 
shifts; offered HbA1c testing to patients and specialize in Cardiology more likely to offer 
lifestyle counseling. Cardiologist may be more likely to offer diet and physical activity 
counseling because of the health severity of the patients they encounter during medical patient 
visit in comparison to other specialties. Logically, patients who receive HbA1c testing are more 
likely to receive counseling makes sense. HbA1c is the main tool of observing the pattern of 
blood sugar levels over time. Finally, EMR capabilities meeting DHHS criteria would create 
variation of offering because physician would have the full scope of patient’s medical history 
and current state of health to make the appropriate and strategic plan to improve the patient’s 
health. Many factors that were observed increased the likelihood of counseling, but other factors 
decreased the likelihood of counseling for diabetic patients. CKD and Cancer patients were 
observed to be less likely to be offered counseling in our analysis. These observations may be 
due to the severity of the chronic disease to which such counseling would be counterproductive 
to the recovery of patients' health, or the sample of cancer and CKD patient are too small for 
analysis. 
  MSA is a variable that represents the Metropolitan status area of the physicians’ location 
in the NAMCS dataset. MSA is census marker to describe the size of a geographic location’s 
population. In the survey, MSA proxy whether physician location is an urban area with a 
population of 50,000 or more [MSA] or rural area with a population of less than 50,000 [Non-
MSA]. The response in the survey for this question is reflected by an answer of MSA or Non-
MSA of the randomly selected physicians’ location in the patient visit. Although it was observed 
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in the univariate analysis that MSA was statistically significant for diet and exercise counseling, 
MSA lost statistical significance when included in the logistic regression model when controlling 
for other non-clinical and clinical variables. A reasonable explanation for these observations is 
the univariate analysis between MSA and the outcome interest, MSA reflected all the variance in 
the relationship between the predictor and outcome variable.  
Details of geographic regions are very important to explaining variations in health 
outcomes in public health research. We hypothesize that the physician location where the patient 
visits may have different levels of certain disease burden accounted for in the MSA variable. For 
example, it is possible for specific physician location have a larger prevalence of comorbidities, 
obesity, access to adequate to healthcare, and food desert relative to other locations in the study. 
When we accounted for all the variables in the model that were attributable to the variations and 
significance via the MSA variable, the statistical significance disappeared in the logistic 
regression model for both types of counseling. Diabetic patient’s that see physicians located in 
more urban area potentially have a higher burden of disease and access to healthcare. As 
previously stated, physicians may offer counseling to sicker patients because of the state of their 
health due to outside factors that influence the disease. 
Unlike many previous studies, the two main strengths of the study are the sample size 
utilized for analysis and the quality of complete patient data for analysis. Although these factors 
are essential for appropriate and unbiased analysis, there were many weaknesses in this study’s 
analysis. Some variables were proxy for other variables for analysis due to the amount of 
“missingness” could have hidden potential additive effects of characteristic variation. For 
example, obesity was substituted for BMI due to 60% of the observation were missing.  
Although BMI clinically determines obesity, the added variance could provide further insight 
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into the physician's medical criteria to offer intervention. HbA1c levels were more than 10% 
missing as well. It is possible exploring the variations among the different BMI [overweight vs. 
obese], and HbA1c [pre-diabetes vs. diabetes] could provide more insight to providing an 
effective treatment for people at risk of diabetes and people diagnosed diabetes.  
More patient information should be collected to give a clearer picture to account for 
socioeconomic characteristics [income, marital status, and zip code] for further explanation of 
variance observed. Other physician and system characteristics that create the variation for 
outcome variables of interest should take into account for future research. There has been 
extensive research that physician’s race, sex, year of experience, and socioeconomic background 
is associated with patient health outcomes and health disparities in the population. For example, 
patients who identify themselves as black women and children tend to have poorer health 
outcomes and mortality rate when it comes to childbirth. 
In our analysis, we examined that the electronic patient records capabilities could 
influence effective care being provided to patients at risk for poor health outcomes. For system 
characteristics, patient-centered medical home status was not available for dataset before 2016 
for analysis. Patient-centered medical home [PCMH] is a medical care delivery model that 
focuses on coordination through primary care doctor to effectively give the patient the care they 
need. This variable would have beneficial for further analysis to gain further insight into the 
system levels relationship with lifestyle counseling.   
Limitations 
 
 One major limitation in the analysis is the size of the survey sample to address the aims 
of the study. After applying inclusion and exclusion criteria to the data observed, 3,463 survey 
observations were left for data analysis. Although we are focusing specifically on U.S. adult 
34 
 
Type II diabetes, the exclusion of patient who were pregnant during patient visit affected the 
sample weights in our analysis. Approximately 27.36% of observations of patient who were 
pregnant, or pregnancy status were unknown where excluded from analysis. The sample weights 
post exclusions are incorrect due to the observations that were included in the calculation of the 
sample weight are no longer in the dataset. Despite the intent of resolving the issue of sample 
size from past research studies with a representative data, there may be issues of generalizability 
for the type II diabetic populations. This impairs the representativeness of the sample despite 
utilizing the sample weights.  
Sample weights were utilized to produce national estimates for patients and physician 
from all four regions of the U.S.; however, for the number of predictors are analysis may need 
more observation in the data for analysis. A survey sample size of 4,000 can’t provide 
implications of the observations that weren’t analyzed. To extrapolate and apply results to the 
overall population, a sufficient statistical power (i.e. adequate sample size) must be attained for 
appropriate analysis for the population. The inferences and generalizability from this research 
study can only be implied to the relevant study sample in analysis, not for all people in the 
population. This could be resolved by extending the timepoint for data analysis for the survey 
sample size issue.  
Another limitation in the study analysis was the questions that were asked for the 
NAMCS survey. This limitation is the major factor for the lack of statistical power and sample 
size issue. The survey question utilized to identify patients that were pregnant wasn’t recorded 
until 2012. Because the uncertainty of the pregnancy status, observation from 2012-2015 were 
included for statistical analysis of lifestyle counseling. Finally, the last limitation would be the 
amount of “missingness” observed throughout the predictor variables in the data. The variables 
35 
 
detected to be a contributor to the burden of DMII and indicators to explain the variations in 
likelihood of lifestyle counseling in previous studies had more than 10% of missing observations. 
This resulted in variables such as BMI and A1c-levels to be proxy for other variables related to 
the ones of interest. Further variation in the survey that was excluded from the analysis could 
have explained the difference in likelihood of counseling for diabetic patients. 
 Future Directions 
 
For future studies, more characteristics on all levels should be examined to develop a 
thorough and complete framework of potential barriers of the interventions to be effective in 
diabetic glycemic control. Once these barriers have been explored, figuring out how much of the 
variations can significantly explain the difference of likelihood of diet and exercise counseling. 
The patient and visit characteristics are nested within provider characteristics in the NAMCS 
dataset so a hierarchal model [generalized mixed effect model] would address if provider and 
system characteristics can explain the difference in the likelihood of diabetic patients offered 
intensive lifestyle counseling. A hierarchal model with the appropriate statistical software is the 
best approach when independence is violated due to the clustering in the dataset. If the 
appropriate measures are taken to analyze specific contributing patient visit characteristics and 
the ability to quantify how much variations account for the lack of translation in the delivery of 
effective glycemic control, then health population and cost of healthcare can improve drastically 
with a noticeable impact shorter than 17 years.  
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Figure 3.1                          List of Patient Visit Characteristics in Analysis 
Patient Variables Physician Variables System Variables 
Patient Race/Ethnicity Geographic region Type of Practice 
Medical Insurance Metropolitan Status Area Owner of Medical Practice 
Patient Age Physician Specialty E-Share with other providers 
Patient Sex Health Provider Type Reminders of interventions/test 
Visit Type Ownership Status of Physician E-share with different EMRs 
Tobacco Use Physician Compensation EMR meet criteria of DHHS 
Total No. Chronic Conditions MD vs DO  
List of chronic conditions HbA1c testing offered to patient  
Time spent with MD   
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TABLE 4.1 
Patient Visit Non-Clinical Characteristics Offered Lifestyle Counseling [Diet/Exercise] 
  Diet/Nutrition Counseling Exercise Counseling 
Variable Total Freq. Frequency [weighted %] p-value Frequency [weighted %] p-value 
Race/Ethnicity   0.0942  0.1541 
Non-Hispanic White 
Non-Hispanic Black 
Hispanic 
Non-Hispanic Other 
2517 427 [13.3281]  311 [9.5767]  
426 84 [4.4136]  64 [2.9158]  
330 79 [6.0416]  55 [4.7104]  
190 19 [1.0110]  14 [0.9154]  
Medical Insurance   0.4550  0.9313 
Non-private 
Private 
1554 265 [9.9834]  180 [7.8612]  
1909 344 [14.8210]  264 [10.2571]  
Age   0.4581  0.4972 
18-34 
35-49 
50-69 
70+ 
69 13 [0.3529]  8 [0.2304]  
436 92 [3.8070]  68 [3.0215]  
1960 366 [14.6715]  266 [10.2613]  
998 138 [5.9729]  102 [4.6051]  
Sex   **0.0212  0.0845 
Male 
Female 
2427 402 [15.4319]  293 [11.3344]  
1036 207 [9.3725]  151 [6.7839]  
Geographic Region   0.5053  0.8474 
Northeast 
Midwest 
South 
West 
439 92 [5.5661]  57 [3.0279]  
1046 173 [3.6263]  123 [2.7680]  
1056 210 [10.2019]  158 [7.5923]  
922 134 [5.4101]  106 [4.7302]  
Metropolitan Status Area   **0.0147  **0.0374 
MSA 
Non-MSA 
3062 556 [23.5889]  410 [17.2255]  
401 53 [1.2155]  34 [0.8928]  
Visit Type   0.7874  0.5104 
New or GME 
Return or Non-GME 
2264 416 [14.9711]  290 [10.3433]  
1199 193 [9.8332]  154 [7.7751]  
Physician Specialty   **0.0112  **0.0195 
General/Family Practice 
Internal Medicine 
Cardiology 
915 220 [11.0523]  160 [8.4163]  
616 130 [6.3567]  94 [3.6326]  
286 64 [2.0905]  57 [1.8415]  
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Neurology/Ophthalmology 
Other  
369 27 [0.2138]  11 [0.0858]  
1277 168 [5.0910]  122 [4.1422]  
Health provider type   0.2163  **0.0271 
Physician 
Mid-level provider 
Other  
3415 603 [24.7418]  442 [18.1353]  
19 2 [0.0864]  1 [0.0432]  
19 3 [0.0351]  1 [0.0081]  
Tobacco Use   **0.0005  0.2837 
No 
Yes 
3352 564 [23.0367]  410 [17.1063]  
111 45 [1.7677]  34 [1.0121]  
Total No. Chronic Condition   0.1466  0.4979 
0-1 
2 or more 
294 32 [1.5954]  21 [1.4398]  
3169 577 [23.2090]  423 [16.6786]  
MD vs DO   0.6653  0.5662 
MD 
DO 
3218 559 [23.0610]  2173 [7.573]  
245 50 [1.7434]  151 [0.4542]  
Ownership Status Physician   0.6639  0.8003 
Full-owner 
Part-owner 
Employee 
Contractor 
956 157 [8.8496]  117 [6.7291]  
847 156 [7.3596]  101 [4.84]  
1564 285 [8.3014]  223 [6.5298]  
83 7 [0.0623]  2 [0.0250]  
Type of Practice   0.3714  0.2767 
Non-Solo 
Solo 
2517 442 [14.4804]  324 [10.1219]  
945 167 [10.3325]  120 [8.0027]  
Basic Compensation***   0.1581  **0.0461 
Fixed Salary 
Share of Practice billing 
Shift, hourly or time based 
Mix of salary and share billings 
Other 
1030 190 [8.0120]  153 [7.1065]  
633 111 [4.6726]  74 [1.7180]  
33 7 [0.2291]  5 [0.1173]  
1394 245 [10.8351]  175 [8.4521]  
200 24 [0.5706]  17 [0.4404]  
Time Spent with MD   **0.0161  0.6347 
0-30 minutes 
31-60 minutes 
≥ 61 minutes 
2986 513 [19.7909]  385 [15.1338]  
436 88 [4.9085]  55 [2.9192]  
41 8 [0.1050]  4 [0.0654]  
Owner of Medical Practice ***   0.2613  0.1546 
Physician/Physician group 521 401 [20.4337]  301 [15.2492]  
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Medical/Academic Health Center 
Insurance company/Health Corp. 
550 110 [2.3928]  82 [1.7274]  
2263 79 [1.8654]  51 [1.1500]  
HbA1c testing offered to patient   0.0638  0.4618 
No 
Yes 
2784 407 [16.0098]  310 [12.5622]  
679 202 [8.7946]  134 [5.5561]  
E-share w/ other providers   0.7697  0.8417 
No 
Yes 
1386 208 [11.3032]  143 [8.8436]  
2077 401 [13.5012]  301 [9.2747]  
Reminders for intervention/test***   0.5763  0.7116 
No 
Yes, used routinely 
Yes, not routinely 
Yes, not used  
395 54 [1.4535]  32 [1.0967]  
2584 461 [19.4025]  340 [13.5632]  
283 49 [1.9446]  37 [1.3058]  
98 26 [0.5980]  23 [0.7376]  
E-share [different systems] ***   0.4926  0.1759 
No 
Yes 
1562 251 [14.2012]  176 [11.3955]  
1480 290 [11.4955]  214 [7.3536]  
EMR meet DHHS criteria ***   0.5406  0.1765 
No 
Yes 
144 14 [3.0884]  16 [3.0077]  
3040 563 [22.4450]  410 [15.9524]  
** p <0.005 is statistically significant 
*** variable is missing less than 10% of observations  
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TABLE 4.2 
Patient Visit Clinical Characteristics Offered Lifestyle Counseling [Diet/Exercise] 
Variable  Diet/Nutrition Counseling Exercise Counseling 
 Total Freq. Frequency [weighted %] p-value Frequency [weighted%] p-value 
Alzheimer   0.4764  0.9726 
No 3441  604 [24.6110]  442 [18.0186]  
Yes 22  5 [0.1933]  2 [0.0997]  
Arthritis   0.0690  **0.0386 
No 2809 497 [19.3787]  349 [13.6928]  
Yes 654 112 [5.4257]  95 [4.4256]  
Asthma   0.7525  0.8226 
No 3205 573 [23.3168]  417 [16.8599]  
Yes 258 36 [1.4875]  27 [1.2584]  
Cancer   **0.0006  0.3333 
No 3119 569 [23.7552]  411 [16.877]  
Yes 344 40 [1.0492]  33 [1.2407]  
Cerebrovascular Disease   0.1532  0.3372 
No 3306 585 [24.3348]  425 [17.7487]  
Yes 157 24 [0.4696]  19 [0.3696]  
Chronic Kidney   0.7203  0.1722 
No 3073 522 [21.4254]  399 [16.7197]  
Yes 390 87 [3.3789]  45 [1.3986]  
COPD   0.5593  0.1068 
No 3203 565 [23.3998]  403 [16.4144]  
Yes 260 44 [1.4046]  41 [1.7040]  
Congestive Heart Failure   0.1707  0.1584 
No 3295 581 [24.2532]  423 [17.7329]  
Yes 168 28 [0.5512]  21 [0.3855]  
Coronary Artery Disease   0.6378  0.9018 
No 2789 478[20.1478]  346 [15.0337]  
Yes 674 131 [4.6565]  98 [3.0847]  
Depression   0.6164  0.3637 
No 3019 517 [22.2708]  380 [16.4174]  
Yes 444 92 [2.5336]  64 [1.7009]  
End of Stage Renal Disease   0.8047  0.1459 
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No 3422 600 [24.5501]  442 [18.0621]  
Yes 41 9 [0.2543]  2 [0.0563]  
Pulmonary Embolism   **<.0001  0.9103 
No 3421 604 [24.7559]  441 [17.8934]  
Yes 42 5 [0.0485]  3 [0.2249]  
HIV   0.2205  0.1200 
No 3448 606 [24.7786]  443 [18.1089]  
Yes 15 3 [0.0258]  1 [0.0094]  
Hyperlipidemia   **0.0168  0.3819 
No 1651 212 [9.1276]  158 [7.6942]  
Yes 1812 397 [15.6768]  286 [10.4242]  
Hypertension   0.9145  0.8766 
No 1015 151 [7.3900]  106 [5.3429]  
Yes 2448 458 [17.4143]  338 [2.7755]  
Obesity   **<.0001  **<.0001 
No 2663 375 [16.2106]  254 [10.9633]  
Yes 800 234 [8.5938]  190 [7.1551]  
Sleep Apnea   0.7455  0.7255 
No 3119 539 [23.1011]  393 [16.9041]  
Yes 344 70 [1.7032]  51 [1.2142]  
Osteoporosis   0.2792  0.3609 
No 3407 601 [24.5822]  434 [17.7567]  
Yes 56 8 [0.2222]  10 [0.3616]  
Substance abuse   0.3070  0.5758 
No 3368 587 [24.0117]  424 [17.834]  
Yes 95 22 [0.7927]  20 [0.3350]  
Alcohol abuse   0.3385  0.3422 
No 3427 601 [24.6677]  440 [18.0299]  
Yes 36 8 [0.1366]  4 [0.0884]  
** p <0.005 is statistically significant 
*** variable is missing less than 10% of observations  
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Table 4.3 
Parameter Estimates and Odds Ratio of Patient and Physician Characteristics Diet Counseling 
Characteristics Estimate SE T-value P-value OR OR 95% CI 
Intercept -3.8350 0.9789 -3.92 **<.0001 ----------- ----------- ----------- 
Physician Specialty    **0.0435    
General/Family Practice 
Cardiovascular 
Internal Medicine 
**Neurology/Ophthalmology 
Other 
----------- ----------- -----------  1.00 [REF] ----------- ----------- 
-0.0947 0.5654 -0.17  0.910 0.300 2.757 
-0.5127 0.3579 -1.43  0.599 0.297 1.208 
-1.6346 0.5435 -3.01  0.195 0.067 0.566 
0.1710 0.3779 -0.45  0.843 0.402 1.768 
Medical Insurance    0.8382    
Non-Private 
Private 
----------- ----------- -----------  1.00 [REF] ----------- ----------- 
0.0451 0.2207 0.20  1.046 0.679 1.613 
Hypertension    0.6983    
No  
Yes 
----------- ----------- -----------  1.00 [REF] ----------- ----------- 
-0.0994 0.2565 -0.39  0.905 0.547 1.497 
HbA1c testing offered     **0.0459    
No  
Yes 
----------- ----------- -----------  1.00 [REF] ----------- ----------- 
0.4793 0.2400 2.00  1.615 1.009 2.585 
Method of basic compensation    **0.0431    
Fixed Salary  
Mix salary and share billings 
Share of Practice billings 
**Shift, hourly  
Other 
----------- ----------- -----------  1.00 [REF] ----------- ----------- 
0.4181 0.3201 1.31  1.519 0.811 2.846 
0.2955 0.4124 0.72  1.344 0.599 3.017 
1.6808 0.5608 3.00  5.370 1.788 16.128 
0.0706 0.5703 -0.12  0.932 0.305 2.851 
Sex    0.5359    
Male  
Female 
----------- ----------- -----------  1.00 [REF] ----------- ----------- 
0.1465 0.2366 0.62  1.158 0.728 1.841 
Metropolitan Stat. Area    0.0824    
Non-MSA 
MSA 
----------- ----------- -----------  1.00 [REF] ----------- ----------- 
0.6521 0.3753 1.74  1.920 0.920 4.007 
 Reminders for intervention/Screening test    0.9558    
No 
Yes, but not used 
Yes, but not routinely used 
Yes, used routinely 
----------- ----------- ----------- ----------- 1.00 [REF] ----------- ----------- 
-0.1306 0.9199 -0.14  0.878 0.145 5.329 
-0.3792 0.7733 -0.49  0.684 0.150 3.118 
-0.3254 0.6663 -0.49  0.722 0.196 2.667 
Current EMR meet DHHS criteria    **0.0042    
No 
Yes 
----------- ----------- ----------- ----------- 1.00 [REF] ----------- ----------- 
1.8763 0.6548 2.87  6.529 1.808 23.578 
Provider seen during patient visit    0.0270    
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Physician  
Mid-level provider 
**Other 
----------- ----------- ----------- ----------- 1.00 [REF] ----------- ----------- 
0.0725 0.7644 0.09  1.075 0.240 4.814 
-2.4765 0.9225 -2.68  0.084 0.014 0.513 
Race/Ethnicity    0.0694    
Non-Hispanic White 
Non-Hispanic Black 
**Hispanic 
Non-Hispanic Other 
----------- ----------- ----------- ----------- 1.00 [REF] ----------- ----------- 
0.2906 0.3402 0.85  1.337 0.686 2.606 
0.7296 0.2838 2.57  2.074 1.189 3.618 
-0.1161 0.7490 -0.16  0.890 0.205 3.868 
Physician’s Region    0.1763    
Northeast 
Midwest 
South 
West 
----------- ----------- ----------- ----------- 1.00 [REF] ----------- ----------- 
-0.8567 0.4476 -1.91  0.425 0.176 1.021 
-0.2690 0.3590 -0.75  0.764 0.378 1.545 
-0.9565 0.5515 -1.73  0.384 0.130 1.133 
Chronic Kidney Disease [CKD]    0.2160    
No 
Yes 
----------- ----------- ----------- ----------- 1.00 [REF] ----------- ----------- 
-0.4432 0.3582 -1.24  0.642 0.318 1.296 
Tobacco Use    0.4698    
No 
Yes 
----------- ----------- ----------- ----------- 1.00 [REF] ----------- ----------- 
0.4309 0.5962 0.72  1.539 0.478 4.953 
Hyperlipidemia    0.0911    
No  
Yes 
----------- ----------- ----------- ----------- 1.00 [REF] ----------- ----------- 
0.3642 0.2155 1.69  1.439 0.943 2.196 
Obesity    **0.0002    
No  
Yes 
----------- ----------- ----------- ----------- 1.00 [REF] ----------- ----------- 
0.9260 0.2484 3.73  2.524 1.551 4.109 
Total Chronic Disease    0.8506    
0-1 
2 or more 
----------- ----------- ----------- ----------- 1.00 [REF] ----------- ----------- 
0.1269 0.6737 0.19  1.135 0.303 4.254 
Arthritis    0.4045    
No  
Yes 
----------- ----------- ----------- ----------- 1.00 [REF] ----------- ----------- 
0.1881 0.2256 0.83  1.207 0.776 1.878 
Asthma    0.2825    
No  
Yes 
----------- ----------- ----------- ----------- 1.00 [REF] ----------- ----------- 
0.1881 0.2256 0.83  0.631 0.273 1.461 
Cancer    **0.0114    
No 
Yes 
----------- ----------- ----------- ----------- 1.00 [REF] ----------- ----------- 
-0.6949 0.2743 -2.53  0.499 0.291 0.855 
Cerebrovascular Disease    0.7239    
No  
Yes 
----------- ----------- ----------- ----------- 1.00 [REF] ----------- ----------- 
-0.1380 0.3904 -0.35  0.871 0.405 1.873 
45 
 
Chronic Obstructive Pulmonary Disease    0.4377    
No  
Yes 
----------- ----------- ----------- ----------- 1.00 [REF] ----------- ----------- 
0.2760 0.3555 0.78  1.318 0.656 2.646 
Congestive heart failure    0.2405    
No  
Yes 
----------- ----------- ----------- ----------- 1.00 [REF] ----------- ----------- 
-0.4913 0.4185 -1.17  0.612 0.269 1.390 
Coronary artery disease    0.2397    
No  
Yes 
----------- ----------- ----------- ----------- 1.00 [REF] ----------- ----------- 
0.3119 0.2652 1.18  1.366 0.812 2.298 
Depression    0.8514    
No  
Yes 
----------- ----------- ----------- ----------- 1.00 [REF] ----------- ----------- 
0.0642 0.3426 0.19  1.066 0.545 2.088 
End Stage Renal Disease    0.8398    
No 
Yes 
----------- ----------- ----------- ----------- 1.00 [REF] ----------- ----------- 
-0.1224 0.6056 -0.20  0.885 0.270 2.901 
History of pulmonary embolism    0.0763    
No 
Yes 
----------- ----------- ----------- ----------- 1.00 [REF] ----------- ----------- 
-1.4667 0.8271 -1.77  0.231 0.046 1.168 
HIV    0.0874    
No  
Yes 
----------- ----------- ----------- ----------- 1.00 [REF] ----------- ----------- 
-2.0024 1.1709 -1.71  0.135 0.014 1.341 
Obstructive Sleep apnea    0.4607    
No  
Yes 
----------- ----------- ----------- ----------- 1.00 [REF] ----------- ----------- 
-0.1802 0.2442 -0.74  0.835 0.517 1.348 
Osteoporosis    0.2093    
No 
Yes 
----------- ----------- ----------- ----------- 1.00 [REF] ----------- ----------- 
-0.8257 0.6574 -1.26  0.438 0.121 1.590 
Substance abuse/dependence    0.3222    
No 
Yes 
----------- ----------- ----------- ----------- 1.00 [REF] ----------- ----------- 
0.7705 0.7781 0.99  2.161 0.470 9.937 
Alcohol Abuse or dependence    0.3309    
No 
Yes 
----------- ----------- ----------- ----------- 1.00 [REF] ----------- ----------- 
-0.5914 0.6081 -0.97  0.554 0.168 1.824 
Practice share PHI electronically    0.1746    
No 
Yes 
----------- ----------- ----------- ----------- 1.00 [REF] ----------- ----------- 
0.4704 0.3464 1.36  1.601 0.811 3.157 
Ownership of Medical Practice    0.2115    
Physician or Physician Group  
Medical/Academic Health Center 
Insurance company, health plan  
----------- ----------- ----------- ----------- 1.00 [REF] ----------- ----------- 
-0.2942 0.3983 -0.74  0.529 0.259 1.080 
-0.6364 0.3636 -1.75  0.745 0.341 1.627 
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*All variables in the dataset Odds ratios are adjusted to the model constructed for diet/nutrition counseling offer 
** p-value < 0.05 is statistically significant 
REF= reference group 
 
 
TABLE 4.4 
Parameter Estimates and Odds Ratio of Patient and Physician Characteristics Exercise Counseling 
Characteristics Estimate SE T-value P-value OR OR 95% CI 
Intercept -2.4287 1.1371 -2.14 **0.0328 ----------- ----------- ----------- 
Physician Specialty    **0.0108    
General/Family Practice 
Cardiovascular 
**Internal Medicine 
**Neurology/Ophthalmology 
Other 
----------- ----------- ----------- ----------- 1.00 [REF] ----------- ----------- 
0.3378 0.5890 0.57  1.402 0.442 4.450 
0.8141 0.3869 -2.10  0.443 0.207 0.946 
-2.3570 0.7859 -3.00  0.095 0.020 0.442 
-0.0390 0.4006 -0.10  0.962 0.438 2.110 
Medical Insurance    0.6094    
Non-Private 
Private 
----------- ----------- ----------- ----------- 1.00 [REF] ----------- ----------- 
-0.1163 0.2275 -0.51  0.890 0.570 1.391 
Hypertension    0.7551    
No  
Yes 
----------- ----------- ----------- ----------- 1.00 [REF] ----------- ----------- 
0.0805 0.2580 0.31  1.084 0.653 1.798 
HbA1c testing offered     0.2110    
No  
Yes 
----------- ----------- ----------- ----------- 1.00 [REF] ----------- ----------- 
0.3260 0.2605 1.25  1.385 0.831 2.309 
Method of basic compensation    0.1821    
Fixed Salary  
Mix salary and share billings 
Share of Practice billings 
Shift, hourly  
Other 
----------- ----------- ----------- ----------- 1.00 [REF] ----------- ----------- 
0.0294 0.3458 0.08  1.030 0.523 2.029 
-0.8216 0.4433 -1.85  0.440 0.184 1.049 
0.1358 0.6305 0.22  1.145 0.333 3.944 
-0.6011 0.6851 -0.88  0.548 0.143 2.101 
Sex    0.3897    
Male  
Female 
----------- ----------- ----------- ----------- 1.00 [REF] ----------- ----------- 
-0.1711 0.1989 -0.86  0.843 0.571 1.245 
Metropolitan Stat. Area    0.1621    
Non-MSA 
MSA 
----------- ----------- ----------- ----------- 1.00 [REF] ----------- ----------- 
0.6468 0.4624 1.40  1.909 0.771 4.728 
 Reminders for intervention/Screening test    0.3392    
No 
Yes, but not used 
----------- ----------- ----------- ----------- 1.00 [REF] ----------- ----------- 
0.6585 0.9447 0.70  1.932 0.303 12.318 
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Yes, but not routinely used 
Yes, used routinely 
-0.7251 0.7979 -0.91  0.484 0.101 2.315 
-0.4810 0.7283 -0.66  0.618 0.148 2.578 
Current EEMR meet DHHS criteria    0.4153    
No 
Yes 
----------- ----------- ----------- ----------- 1.00 [REF] ----------- ----------- 
0.5664 0.6952 0.81  1.762 0.451 6.886 
Provider seen during patient visit    0.0282    
Physician  
Mid-level provider 
**Other 
----------- ----------- ----------- ----------- 1.00 [REF] ----------- ----------- 
-0.7917 0.7215 -1.10  0.453 0.110 1.865 
-2.9077 1.1883 -2.45  0.055 0.005 0.561 
Race/Ethnicity    0.5496    
Non-Hispanic White 
Non-Hispanic Black 
Hispanic 
Non-Hispanic Other 
----------- ----------- ----------- ----------- 1.00 [REF] ----------- ----------- 
0.2216 0.3329 0.67  1.248 0.650 2.397 
0.4487 0.3429 1.31  1.566 0.800 3.068 
0.4096 0.6754 0.61  1.506 0.401 5.664 
Physician’s Region    0.4160    
Northeast 
Midwest 
South 
West 
----------- ----------- ----------- ----------- 1.00 [REF] ----------- ----------- 
-0.2521 0.5008 -0.50  0.777 0.291 2.075 
0.2925 0.4212 0.69  1.340 0.587 3.060 
-0.2305 0.5687 -0.41  0.794 0.260 2.422 
Chronic Kidney Disease [CKD]    **0.0007    
No 
Yes 
----------- ----------- ----------- ----------- 1.00 [REF] ----------- ----------- 
-1.6083 0.4765 -3.38  0.200 0.079 0.510 
Tobacco Use    0.5733    
No 
Yes 
----------- ----------- ----------- ----------- 1.00 [REF] ----------- ----------- 
0.2991 0.5309 0.56  1.349 0.476 3.820 
Hyperlipidemia    0.0845    
No  
Yes 
----------- ----------- ----------- ----------- 1.00 [REF] ----------- ----------- 
0.3795 0.2199 1.73  1.462 0.950 2.250 
Obesity    **<.0001    
No  
Yes 
----------- ----------- ----------- ----------- 1.00 [REF] ----------- ----------- 
1.4501 0.2609 5.56  4.264 2.556 7.112 
Total Chronic Disease    0.6076    
0-1 
2 or more 
----------- ----------- ----------- ----------- 1.00 [REF] ----------- ----------- 
-0.3429 0.6678 -0.51  0.710 0.192 2.629 
Arthritis    0.1153    
No  
Yes 
----------- ----------- ----------- ----------- 1.00 [REF] ----------- ----------- 
0.4296 0.2727 1.58  1.537 0.900 2.623 
Asthma    0.1946    
No  
Yes 
----------- ----------- ----------- ----------- 1.00 [REF] ----------- ----------- 
-0.6154 0.4743 -1.30  0.540 0.213 1.370 
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Cancer    0.6545    
No 
Yes 
----------- ----------- ----------- ----------- 1.00 [REF] ----------- ----------- 
-0.1294 0.2892 -0.45  0.879 0.498 1.549 
Cerebrovascular Disease    0.8302    
No  
Yes 
----------- ----------- ----------- ----------- 1.00 [REF] ----------- ----------- 
-0.0954 0.4450 -0.21  0.909 0.380 2.175 
Chronic Obstructive Pulmonary Disease    **0.0010    
No  
Yes 
----------- ----------- ----------- ----------- 1.00 [REF] ----------- ----------- 
1.0659 0.3249 3.28  2.904 1.535 5.490 
Congestive heart failure    0.5075    
No  
Yes 
----------- ----------- ----------- ----------- 1.00 [REF] ----------- ----------- 
-0.3994 0.6025 -0.66  0.671 0.206 2.186 
Coronary artery disease    0.8668    
No  
Yes 
----------- ----------- ----------- ----------- 1.00 [REF] ----------- ----------- 
-0.0523 0.3116 -0.17  0.949 0.515 1.749 
Depression    0.7354    
No  
Yes 
----------- ----------- ----------- ----------- 1.00 [REF] ----------- ----------- 
-0.0857 0.2536 -0.34  0.918 0.558 1.509 
End Stage Renal Disease    0.4961    
No 
Yes 
----------- ----------- ----------- ----------- 1.00 [REF] ----------- ----------- 
-0.7513 1.1037 -0.68  0.472 0.054 4.109 
History of pulmonary embolism    0.8413    
No 
Yes 
----------- ----------- ----------- ----------- 1.00 [REF] ----------- ----------- 
-0.1549 0.7734 -0.20  0.856 0.188 3.903 
HIV    0.2921    
No  
Yes 
----------- ----------- ----------- ----------- 1.00 [REF] ----------- ----------- 
-1.2340 1.1710 -1.05  0.291 0.029 2.893 
Obstructive Sleep apnea    0.3765    
No  
Yes 
----------- ----------- ----------- ----------- 1.00 [REF] ----------- ----------- 
-0.2724 0.3079 -0.88  0.762 0.416 1.393 
Osteoporosis    0.9445    
No 
Yes 
----------- ----------- ----------- ----------- 1.00 [REF] ----------- ----------- 
0.0391 0.5615 0.07  1.040 0.346 3.127 
Substance abuse/dependence    0.6303    
No 
Yes 
----------- ----------- ----------- ----------- 1.00 [REF] ----------- ----------- 
0.2280 0.4737 0.48  1.256 0.496 3.180 
Alcohol Abuse or dependence    0.2962    
No 
Yes 
----------- ----------- ----------- ----------- 1.00 [REF] ----------- ----------- 
-0.7900 0.7561 -1.04  0.454 0.103 1.999 
Practice share PHI electronically    0.3011    
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No 
Yes 
----------- ----------- ----------- ----------- 1.00 [REF] ----------- ----------- 
0.3764 0.3638 1.03  1.457 0.714 2.974 
Ownership of Medical Practice    0.1389    
Physician or Physician Group  
Medical/Academic Health Center 
Insurance company, health plan  
----------- ----------- ----------- ----------- 1.00 [REF] ----------- ----------- 
-0.4118 0.4620 -0.89  0.662 0.268 1.639 
-0.8872 0.4487 -1.98  0.412 0.171 0.993 
*All variables in the dataset Odds ratios are adjusted to the model constructed for exercise counseling offer 
** p-value < 0.05 is statistically significant 
REF= reference group 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
50 
 
 
